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Abstract
Background: Population ageing is expected to lead to strong increases in the number of persons with one or more
disabilities, which may result in substantial declines in the quality of life. To reduce the burden of disability and to prevent
concomitant declines in the quality of life, one of the first steps is to establish which diseases contribute most to the burden.
Therefore, this paper aims to determine the contribution of specific diseases to the prevalence of disability and to years
lived with disability, and to assess whether large contributions are due to a high disease prevalence or a high disabling
impact.
Methodology/Principal Findings: Data from the Dutch POLS-survey (Permanent Onderzoek Leefsituatie, 2001–2007) were
analyzed. Using additive regression and accounting for co-morbidity, the disabling impact of selected chronic diseases was
calculated, and the prevalence and years lived with ADL and mobility disabilities were partitioned into contributions of
specific disease. Musculoskeletal and cardiovascular disease contributed most to the burden of disability, but chronic non-
specific lung disease (males) and diabetes (females) also contributed much. Within the musculoskeletal and cardiovascular
disease groups, back pain, peripheral vascular disease and stroke contributed particularly by their high disabling impact.
Arthritis and heart disease were less disabling but contributed substantially because of their high prevalence. The disabling
impact of diseases was particularly high among persons older than 80.
Conclusions/Significance: To reduce the burden of disability, the extent diseases such as back pain, peripheral vascular
disease and stroke lead to disability should be reduced, particularly among the oldest old. But also moderately disabling
diseases with a high prevalence, such as arthritis and heart disease, should be targeted.
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Introduction
Population ageing is expected to lead to a sharp increase in the
occurrence of disability. Disability is associated with an increased
need for social services, e.g. healthcare, and a loss in quality of life
[1,2,3]. To enable the future health care system to cope with
increasing demands, and to avoid strong decrements in the quality
of life, it is crucial to develop strategies that effectively lead to
reductions in the burden of disability. One of the first steps crucial
in developing these strategies is to identify which diseases
contribute most to the total burden of disability, but also to clarify
whether large contributions are related with a high prevalence of
disease or with a high disabling impact, i.e. a high extent the
disease leads to disability.
To date, only a limited number of studies have assessed the
contribution of specific diseases to the burden of disability
[4,5,6,7,8,9,10,11,12,13,14]. Unfortunately, most of these studies
were based on relatively old data [4,5,6,7,8,9]. As both the
prevalence of chronic diseases and their disabling impacts change
over time, the results of these studies may be outdated [13,14].
Furthermore, only two studies explicitly addressed the role of
disease prevalence and disabling impact in contributions to
disability [5,6]. The most comprehensive study assessing burden
of disease has probably been WHOs Global Burden of Disease
study (GBD) [12]. In this study, however, disease burden is
quantified on the basis of panel valuations of health states rather
than actual presence of physical or mental disabilities [12].
Most of the previous studies were based on cause elimination
techniques, which provide outcome measures that reflect the
reduction in the prevalence of disability if the disease would no
longer be present [4,7,8,11]. Drawbacks of this method are that
the results may be inconsistent in a situation of co-morbidity, as
they depend on the ordering of the elimination, and that
contributions of all diseases do not add up to the total disability
prevalence. Recently, Nusselder et al. developed a methodology,
based on an additive regression technique, that enables exact
partitioning of the burden of disability into additive contributions
of disease in the presence of co-morbidity [5,15].
The aim of this study was to investigate the current contribution
of specific chronic diseases to the total burden of disability in
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terms of disability prevalence and years lived with disability. This
study is among the first to highlight the role of both the prevalence
and the disabling impact of specific diseases to determine their
contribution to the burden of disability.
Methods
Study population
The study population consisted of subjects from seven successive
years (2001–2007) of the POLS health and labor survey, which is
being conducted by Statistics Netherlands. The survey does not
include the institutionalized population. To account for selective
non-response and to ensure representativeness for the Dutch non-
institutionalized population, weights were used that were attached
to the data.
Information on disabilities in mobility and activities of daily
living was collected through face-to-face interviews and informa-
tion on the presence of chronic disease through written
questionnaires. From 2001–2007, 110,766 subjects were ap-
proached and the response was 62%. For our analyses selected
elderly subjects who were 55 years and older (n=17,404) were
selected. 22% of these subjects could not be included in the study
population because they lacked disease information. Table 1
provides further detailed information on numbers of persons in the
study population and Figure 1 on the difference between the
source and study population.
Disability
Subjects were asked if they were able to ‘walk up and down the
stairs’, ‘walk outside’, ‘enter/leave the house’, ‘sit down/get up
from a chair’, ‘move around on the same floor’, ‘get in/out of bed’,
Figure 1. Prevalence of disability by age. The source population consisted of all respondents to the POLS health and labor survey, the
Netherlands, 2001–2007, aged 55 and older (n=17,404). The study population equals the source population minus all subjects who had information
missing on the presence of diseases (n=13,635).
doi:10.1371/journal.pone.0025325.g001
Table 1. Numbers of subjects in the study sample.
males females
55–64 65–79 .=80 55–64 65–79 .=80
total 3412 2873 478 3187 3005 680
elementary education 531 695 149 680 1160 359
secondary education 1928 1499 232 2003 1546 265
tertiary education 932 656 95 495 286 52
education missing 21 23 2 9 13 4
DM 262 365 55 168 353 97
stroke 130 233 50 88 159 53
heart disease 330 599 116 107 297 100
PVD 119 207 50 72 183 67
cancer 130 278 66 244 306 80
CNSLD 229 283 61 239 314 67
backpain 414 258 46 380 407 102
arthritis 580 629 147 868 1254 358
disorder neck/arm 432 316 46 623 577 127
other 600 487 118 918 906 269
no disease reported 1620 1014 119 1283 845 131
ADL disabled 137 263 96 200 472 254
Abbreviations: CNSLD = chronic non-specific lung disease; DM = diabetes
mellitus; PVD = peripheral vascular disease (upper extremity excluded).
Numbers of persons with diseases do not add up to total because of
co-existence of diseases.
doi:10.1371/journal.pone.0025325.t001
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completely’ and could answer with ‘without difficulty’, ‘with minor
difficulty’, ‘with major difficulty’ and ‘only with help’. Someone
was considered disabled if he or she opted for one of the latter two
answers at least once.
Definition of disease groups
Information on the presence of a range of diseases was collected
in the questionnaire. From the original questions ‘cardiovascular
disease’ (CVD) was compiled, containing ‘stroke’, ‘heart disease’
and ‘peripheral vascular disease (PVD)’, and ‘musculoskeletal
disease’ was compiled, containing ‘back pain’, ‘arthritis’ and
‘disorder neck/arm’. Furthermore, ‘diabetes mellitus (DM)’,
‘cancer’, ‘chronic non-specific lung disease (CNSLD)’ and ‘other’
were distinguished. Appendix S1 shows the original questions and
the diseases that were distinguished. Skin cancer was not included
because it is not associated with disability. PVD did not include
vascular disease of the upper extremity. In subjects who had
suffered from back pain or disorders of the neck/arm but indicated
that they currently did not suffer anymore, the condition was
regarded as no longer present. If a disease was defined on the basis
of multiple questions and information on any of the questions was
missing while none of the questions indicated the presence of a
disease, the disease information was considered missing.
Statistical methods
Disability prevalence by cause was estimated from individual
information on the presence or absence of disability, the presence or
absence of the selected disease groups, gender and age. A method
based on a multivariate additive regression model was used, which is
described in more detail elsewhere [5,6,16]. This method takes into
account that persons who do not report a disease may be disabled (this
risk is referred to as ‘‘background’’) and that persons can have more
than one disease (co-morbidity). Disability in persons without a
reported disease is entirely attributed to background. Disability in
persons with at least one disease is attributed partly to background and
partly to the disease(s). We assume that causes of disability (diseases
and background risk) act as independently competing causes.
Assuming independence, the hazard of someone having disease A
and B (and zero background risk) equals hazard A + hazard B. In a
situation of no competing risk (one disease and zero background risk)
the hazard can be easily converted to a probability of being disabled
(1-exp(- disease hazard)). When more causes are competing, the
probability of being disabled from the specific disease is lower than in
the situation of no competition. In the footnote of table 2, a calculation
example is given of how was dealt with co-morbidity.
To estimate cause-specific disability prevalence from cross-
sectional data the following assumptions were made. First, the
distribution of disability by cause is explained entirely by diseases
that are (still) present at the time of the survey and the risk of
disability in absence of any reported diseases. Second, this
distribution is proportional to the distribution of the risk of
becoming disabled in the time-period preceding the survey.
Thirdly, causes of disability (diseases and background) act as
independently competing causes.
The regression model is specified as follows:





where ^ y y is the estimated probability that the person has disability,
e is the base of the natural logarithm and g the linear predictor.
The latter is defined as the sum of the background rate by age (aa)
and the cause-specific rates of disability (bd, labeled as ‘‘disabling
impact’’) for the disease groups (d) that are present in the
respondent (given by the dummy variables Xd). Background was
handled as a cause that is prevalent for everyone; the rate of
background is age dependent (5-year age groups). The disabling
impact bd may also vary by age. As the full age-interaction term
would require n (number of age classes) times m (number of
diseases) different parameters, the rank of the interaction was
reduced to one, which means that the age-specific disabling impact
of each disease, bda, is estimated as the product of an age patternca
which is equal for each disease, and a disease effect dd, which
varies by disease, but not by age (Reduced Rank Regression)
[17,18]. While a one rank solution restricts the age pattern to be
the same for all diseases, also second rank solutions were fitted
(bda~ca1:dd1zca2:dd2) and scaled deviances were compared to
test for differences in age patterns for different diseases. Adding a
one rank interaction improved the fit of the model (log-likelihood
ratio test with P-value of 0.05), indicating that the disabling impact
varies by age. Because adding a second rank did not further
improve the fit of the model, the same age pattern for all diseases
was used. Models were fitted using a quasi-Newton method that
was programmed for the statistical package R version 2.7.1. [19].
All analyses were done seperately for men and women, as the log-
likelihood ratio test indicated that both the rates of background
and the disease-specific rates given sex-specific rates of background
differed signifcantly by sex. The significance of the differences in
the disabling impact between males and females was assessed by
assuming normal distribution of the parameters with the mean of
the original ones as the standard error.
Calculation of number of disabled by cause across
subgroups
Disability prevalence by cause depends on the prevalence of the
disease (Xd) and the disabling impact of the disease (bd or bda).
Analogous to using the proportional distribution of mortality rates
to obtain probabilities of death in the presence of competing
causes (so called ‘‘crude probabilities’’), the attribution of disease d
is (bdXd=g):y and of background is (aa=g):y [5,6]. Applying these
formulas gives for every individual the probability of being
disabled caused by background or disease (if present). Adding the
cause-specific probabilities of an individual gives the probability of
being disabled for that individual. Adding the cause-specific
probabilities of all persons in the dataset, or in a specific age group,
gives the total number of disabled by cause in the population, or in
that age group. Dividing the number of disabled persons by cause
by the total number of persons gives the proportion of disability by
cause.
Years lived with disability at age 55 by cause were obtained
using the Sullivan method [20]. The Sullivan method uses the
prevalence of disability in each age group to divide the number of
person-years into years lived with and without disability [20].
Instead of using the age and sex specific prevalence of disability,
we used age, sex and cause specific prevalence of disability,
yielding the years with disability by each cause. Adding the years
with disability by each cause yields the life expectancy with
disability, as the sum of the cause-specific disability add to the total
prevalence. A life table for the Dutch population 2001–2007,
available from the EHEMU database, was used [21].
Confidence intervals around the estimates of disabling impacts,
prevalences of disability by cause and contributions to LED at age
55 were obtained with bootstrapping based on 1000 replicas [22].
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parametric bootstrapping. For the bootstrap of life expectancy,
which is used in combination with prevalence by cause to calculate
LED, we used parameterized bootstrap, assuming Poisson
distribution of the numbers of deaths.
The software for additive regression and for calculation of
disability prevalence by cause is available from the authors on
request.
Results
In males, the prevalence of disability increased from 4% at ages
55–59 to 20% at ages older than 80. In females, this was from 6%
to 37% (Figure 1). Also persons without any disease reported
disability.
The contribution of diseases to the prevalence of disability
depends both on the prevalence and disabling impact of disease.
Among males, arthritis, heart disease and other, and at younger
ages also back pain, had the highest prevalences (Table 2). Among
females these were arthritis, other, disorder neck/arm and back
pain, and at older ages also DM and heart disease.
Among males, PVD had the highest disabling impact (Table 2).
Furthermore, stroke, CNSLD and back pain showed high
disability risks. Among females, back pain had the highest
disabling impact, but stroke and PVD also showed high impacts.
In both sexes, cancer did not lead to much disability, as was the
case for DM and heart disease in males. The disabling impacts of
DM, heart disease, arthritis and disorder neck/arm were
significantly higher among females than among males (p,0.05).
Although the disabling impact of cancer was low, it was
significantly higher among males. The disabling impact of the
diseases increased with age (P,0.05).
In males, the most important contributors to the prevalence of
disability were musculoskeletal disease and CVD (Table 3,
Figure 2). Musculoskeletal disease accounted for 40% of the
prevalence of disability below age 65, which was about twice the
contribution of CVD. At older ages the two conditions contributed
equally. Most of the disability attributed to CVD was caused by
Table 2. Prevalences and disabling impacts of disease.
disease prevalences (%) disabling impacts of disease (hazard)
55–64 65–79 .=80 55–64 65–79 .=80
males
DM 7.7 (6.9–8.7) 12.6 (11.5–13.9) 10.8 (1.6–9.0) 0.01 (0.00–0.02) 0.02 (0.00–0.05) 0.03 (0.00–0.08)
stroke 3.8 (3.2–4.4) 8.1 (7.2–9.1) 10.9 (8.4–14.1) 0.08 (0.05–0.12) 0.16 (0.10–0.23) 0.28 (0.17–0.42)
heart disease 9.6 (8.7–10.6) 20.9 (19.4–22.4) 23.3 (19.8–27.2) 0.01 (0.00–0.03) 0.03 (0.01–0.06) 0.05 (0.01–0.10)
PVD 3.4 (2.9–4.1) 6.9 (6.1–7.9) 10.6 (8.1–13.7) 0.09 (0.05–0.13) 0.17 (0.10–0.26) 0.30 (0.17–0.47)
cancer 3.7 (3.1–4.4) 9.7 (8.7–10.9) 14.3 (11.4–17.8) 0.01 (0.00–0.03) 0.02 (0.00–0.05) 0.04 (0.00–0.09)
CNSLD 6.6 (5.8–7.5) 10.2 (9.1–11.4) 12.6 (9.9–15.9) 0.08 (0.05–0.11) 0.15 (0.10–0.20) 0.26 (0.16–0.38)
backpain 11.9 (10.9–13.0) 8.7 (7.7–9.8) 8.9 (6.7–11.7) 0.08 (0.05–0.11) 0.16 (0.11–0.22) 0.29 (0.17–0.42)
arthritis 16.7 (15.5–18.0) 21.9 (20.4–23.5) 31.0 (27.0–35.3) 0.03 (0.02–0.05) 0.07 (0.04–0.09) 0.12 (0.06–0.19)
disorder neck/arm 12.7 (11.6–13.8) 10.9 (9.8–12.1) 9.5 (7.2–12.4) 0.00 (0.00–0.02) 0.01 (0.00–0.04) 0.01 (0.00–0.08)
other 17.3 (16.1–18.6) 17.4 (16.0–18.8) 25.1 (21.4–29.2) 0.03 (0.01–0.04) 0.05 (0.02–0.08) 0.09 (0.04–0.15)
no disease reported 48.1 (46.4–49.8) 35.4 (33.6–37.1) 25.8 (22.1–30.0)
females
DM 5.4 (4.7–6.2) 11.7 (10.6–12.9) 14.7 (5.9–16.0) 0.07 (0.04–0.10) 0.11 (0.06–0.16) 0.23 (0.13–0.37)
stroke 2.6 (2.1–3.2) 5.2 (4.5–6.1) 7.9 (6.1–10.2) 0.10 (0.05–0.16) 0.16 (0.08–0.24) 0.35 (0.18–0.55)
heart disease 3.2 (2.7–3.9) 9.9 (8.9–11.0) 14.4 (11.9–17.2) 0.06 (0.03–0.10) 0.10 (0.05–0.15) 0.22 (0.11–0.36)
PVD 2.3 (1.8–2.8) 6.4 (5.6–7.4) 9.9 (7.9–12.4) 0.11 (0.06–0.18) 0.17 (0.09–0.27) 0.38 (0.21–0.60)
cancer 7.6 (6.7–8.5) 10.2 (9.2–11.4) 11.5 (9.3–14.0) 0.01 (0.00–0.03) 0.01 (0.00–0.04) 0.03 (0.00–0.09)
CNSLD 7.4 (6.6–8.4) 10.5 (9.4–11.6) 10.2 (8.1–12.8) 0.06 (0.03–0.10) 0.10 (0.05–0.15) 0.22 (0.10–0.34)
backpain 12.1 (11.0–13.3) 13.7 (12.5–15.0) 15.3 (12.7–18.2) 0.12 (0.09–0.16) 0.20 (0.14–0.26) 0.44 (0.30–0.60)
arthritis 27.1 (25.6–28.7) 41.6 (39.9–43.4) 53.6 (49.9–57.3) 0.07 (0.05–0.09) 0.11 (0.08–0.14) 0.24 (0.17–0.32)
disorder neck/arm 19.8 (18.4–21.2) 19.4 (18.0–20.8) 19.7 (16.8–22.9) 0.03 (0.01–0.05) 0.04 (0.01–0.07) 0.09 (0.03–0.17)
other 29.3 (27.7–30.9) 30.4 (28.8–32.1) 39.0 (35.4–42.7) 0.04 (0.02–0.05) 0.06 (0.03–0.09) 0.13 (0.07–0.20)
no disease reported 40.0 (38.3–41.7) 27.9 (26.4–29.6) 19.7 (16.8–22.8)
Abbreviations: CNSLD = chronic non-specific lung disease; DM = diabetes mellitus; PVD = peripheral vascular disease (upper extremity excluded).
5 year age groups were used to calculate the disabling impact of diseases and the prevalence of disability by cause (table 3). To summarize and as is shown in the table,
disabling impacts were also calculated using three age-aggregated groups (55–64.9, 65–79.9, .=80). ‘Background’, representing presence of disability irrespective of
disease presence, is preferably modelled according to 5 year age groups and could therefore not be shown in the table.
The disabling impact represents the rate of disability from a specific cause given that the disease is present. Adding these specific disability rates for the diseases
present and the background rate of disability (by age and gender) gives the total disability rate for a specific exposure group. The proportion of the cause-specific rate
in total rate is used to divide the probability of disability in this group by cause. For example, for males aged 75–79 with PVD and arthritis, adding the background rate
(0.03), the rate for PVD (0.17), and the rate for arthritis (0.07) yields a total disability rate of 0.27 and a total probability of disability of 0.24 (1 2 exp(20.27) =0.24). The
probability of disability from background in this group is 0.03 (0.03/0.27 * 0.24), that of PVD is 0.15 (0.17/0.27 * 0.24), and that of arthritis is 0.06 (0.07/0.27 * 0.24).
The disabling impact for males and females was significantly different (P,0.05) for DM, heart disease, cancer, arthritis and disorder neck/arm.
doi:10.1371/journal.pone.0025325.t002
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attributed to musculoskeletal disease was caused by back pain. At
older ages, the largest part was caused by arthritis. CNSLD
contributed less than musculoskeletal disease and CVD, but was
still responsible for 10–15%. In females, musculoskeletal disease
was by far the most important contributor and accounted for 40–
50% of the disability burden. Disability attributed to musculo-
skeletal disease was mostly caused by arthritis, but back pain was
also an important cause. The second important cause was CVD,
contributing more than 15% in females aged 80 and older. Stroke,
heart disease and PVD all three contributed importantly to the
disability attributed to CVD. DM was also important and
contributed 5–8%.
Diseases contributions to years lived with disability were similar
to contributions to the prevalence of disability (Table 3, Figure 3).
Of the 3.01 years with disability in males, 0.85 were contributed
by CVD and 0.86 by musculoskeletal disease. CNSLD contributed
0.40 years. In females, musculoskeletal diseases were responsible
for 2.93 of the 6.64 life years with disability. The contribution of
arthritis alone (1.75 years) was about 0.8 years more than the
contribution of all CVDs together (0.97 years). DM contributed
0.44 years.
Discussion
This study is among the first to investigate contributions of
various chronic diseases to the prevalence of disability and is the
first to present years lived with disability by cause. Musculoskeletal
disease is the main contributor and CVD, particularly important
among males, is a second. CNSLD is the third contributor among
males and DM among females. Within the group of musculoskel-
etal disease, arthritis-disorder neck arm contributes mostly by a
high prevalence and back pain by a high disabling impact,
although the prevalence of this condition is also high. Within the
group of CVD, heart disease contributes mostly by its high
prevalence and PVD and stroke by its high disabling impact. The
disabling impact of all diseases increases with age.
Evaluation of data and methods/limitations
Selection bias may limit the external validity of the results.
Possible selection bias caused by non-response (38%) was
minimized by using individual weights to adjust for selection
effects by age, gender, marital status, urbanization grade,
province, employment, health- and smoking status [23].
Twenty two percent of all subjects aged 55 and older lacked disease
information and were excluded from the analysis, which led to a slight
Table 3. Contributions of disease to prevalence of disability and to life expectancy with disability at age 55.
contribution to prevalence of disability (% points)




DM 0.08 (0.00–0.19) 0.24 (0.00–0.55) 0.33 (0.00–0.77) 0.06 (0.00–0.14)
stroke 0.28 (0.17–0.42) 1.14 (0.73–1.58) 2.27 (1.37–3.26) 0.34 (0.23–0.46)
heart disease 0.16 (0.06–0.30) 0.66 (0.27–1.15) 1.17 (0.46–2.02) 0.18 (0.08–0.31)
PVD 0.28 (0.15–0.42) 1.07 (0.63–1.51) 2.34 (1.33–3.38) 0.33 (0.20–0.46)
cancer 0.04 (0.00–0.09) 0.19 (0.00–0.42) 0.44 (0.00–1.08) 0.06 (0.00–0.13)
CNSLD 0.45 (0.30–0.66) 1.35 (0.92–1.84) 2.49 (1.49–3.63) 0.40 (0.27–0.53)
back pain 0.92 (0.62–1.26) 1.25 (0.84–1.72) 1.91 (1.09–2.86) 0.39 (0.27–0.52)
arthritis 0.55 (0.31–0.81) 1.41 (0.83–1.92) 3.07 (1.59–4.74) 0.45 (0.26–0.62)
disorder neck/arm 0.04 (0.00–0.23) 0.07 (0.00–0.38) 0.09 (0.00–0.60) 0.02 (0.00–0.11)
other 0.41 (0.19–0.67) 0.82 (0.38–1.31) 1.82 (1.82–1.82) 0.27 (0.12–0.45)
back ground 0.73 (0.28–1.20) 0.97 (0.43–1.61) 4.37 (1.36–7.91) 0.51 (0.29–0.77)
total 3.93 (3.33–4.62) 9.07 (8.08–10.18) 20.37 (16.98–24.24) 3.01 (2.68–3.31)
females
DM 0.33 (0.18–0.51) 1.14 (0.62–1.66) 2.45 (1.30–3.78) 0.44 (0.24–0.65)
stroke 0.21 (0.10–0.35) 0.69 (0.37–1.08) 1.65 (0.89–2.46) 0.28 (0.15–0.42)
heart disease 0.17 (0.08–0.28) 0.85 (0.41–1.30) 2.04 (0.90–3.18) 0.34 (0.16–0.52)
PVD 0.19 (0.08–0.31) 0.86 (0.41–1.30) 2.12 (1.08–3.27) 0.35 (0.18–0.52)
cancer 0.05 (0.00–0.19) 0.11 (0.00–0.41) 0.22 (0.00–0.83) 0.04 (0.00–0.16)
CNSLD 0.42 (0.21–0.63) 0.93 (0.47–1.43) 1.52 (0.77–2.44) 0.32 (0.17–0.48)
back pain 1.30 (0.94–1.74) 2.30 (1.70–2.94) 4.07 (2.92–5.44) 0.86 (0.64–1.08)
arthritis 1.72 (1.27–2.17) 4.35 (3.36–5.25) 9.72 (7.27–12.17) 1.75 (1.36–2.11)
disorder neck/arm 0.46 (0.13–0.84) 0.72 (0.21–1.28) 1.25 (0.35–2.33) 0.27 (0.07–0.48)
other 1.06 (0.66–1.49) 1.78 (1.13–2.58) 3.97 (2.38–5.94) 0.75 (0.46–1.09)
back ground 0.61 (0.21–1.07) 2.04 (1.21–3.00) 8.96 (5.18–13.35) 1.23 (0.82–1.72)
total 6.48 (5.66–7.40) 15.65 (14.39–16.99) 38.07 (34.48–41.80) 6.64 (6.20–7.06)
Abbreviations: CNSLD = chronic non-specific lung disease; DM = diabetes mellitus; PVD = peripheral vascular disease (upper extremity excluded).
doi:10.1371/journal.pone.0025325.t003
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prevalence of disability among non-responders may suggest a slight
underestimation of the prevalence and/or disabling impact of some
diseases, and hence,that our results should be regarded as conservative.
Our results may not be generalizable to the institutionalized
population, which has a higher prevalence of disability and also
the relative contribution of specific diseases to the total burden of
disability inside institutions may differ from our estimates [24,25].
However, in the Netherlands only a minor part of elderly people
lives in an institution (i.e. 90% of those aged 80–85 still live at
home), hence, bias due to excluding the institutionalized
population is probably small and negligible at younger ages [25].
Due to differences in the extent diseases have remained
undiagnosed in the population and due to differences in the
reference periods used in the questionnaire, some variation may
exist in the extent the prevalences derived from the POLS survey
reflect true prevalences. Previous literature showed that self-report
of most chronic conditions is fairly accurate, except for arthritis,
which may be underestimated as well as overestimated [26]. If the
prevalence of arthritis or another disease in our study was
underestimated, subjects with less severe forms of the disease
would be most likely to be uncounted and, hence, the disabling
impact would be overestimated. This implies that although there
may be some bias in the estimates of disease prevalence, this is
nullified by a bias in opposite direction in the disabling impact.
Hence, the bias in the estimates of contributions of specific diseases
to the prevalence of disability and life expectancy with disability is
likely to have remained small. Self-report of ADL disability has
been found to correlate well with performance based measures
and, hence, is expected not to have affected the results
substantially [27].
Figure 2. Prevalence of disability by cause. Abbreviations: CNSLD = chronic non-specific lung disease; CVD = cardiovascular disease; DM =
diabetes mellitus; PVD = peripheral vascular disease (upper extremity excluded). Contributions of specific diseases to the prevalence of disability
were estimated on the basis of diseases prevalence and disabling impact in the study sample from the POLS health and labor survey, the Netherlands,
2001–2007. The disabling impact represents the rate of disability from a specific cause given that the disease is present. Adding specific disability
rates for the diseases present and the background rate of disability (by age and gender) gives the total disability rate for a specific exposure group.
The contributions of specific diseases presented in the figure add up to the total prevalence of disability.
doi:10.1371/journal.pone.0025325.g002
Figure 3. Life expectancy with disability at age 55 by cause.
Abbreviations: CNSLD = chronic non-specific lung disease; CVD =
cardiovascular disease; DM = diabetes mellitus; PVD = peripheral
vascular disease (upper extremity excluded). Contributions of specific
diseases to the life expectancy with disability were estimated on the
basis of estimated contributions of specific disease to the prevalence of
disability in the study sample from the POLS health and labor survey,
the Netherlands, 2001–2007, in combination with life table information
for the Dutch population 2001–2007, available from the EHEMU
database. Methods of decomposition are described elsewhere (5).
doi:10.1371/journal.pone.0025325.g003
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more items answered with ‘‘at least minor difficulty’’ resulted in a
lower percentage of disability explained by the diseases included.
Our substantive conclusions regarding which diseases contributed
most remained unaffected. Due to a lack of power, using a more
stringent cut-level could not be evaluated.
The cross-sectional nature our methods and data did not allow
identifying cases in which disability was present prior to the onset
of the disease. In these cases the disability might be falsely
attributed to the disease.
It was decided not to exclude conditions such as ‘dizziness with
falling’ and ‘involuntary loss of urine’, which have an intermediate
position between diseases and disability, but to add them in a
separate category. Adding this group mainly reduced the
contribution of background, but did not affect the contribution
of the other diseases substantially. In both sexes only ‘dizziness
with falling’ and ‘involuntary loss of urine’ had a high disabling
impact and therefore accounted for most of the contribution of
other (data available on request).
Mental health conditions are a strong predictor of disease burden
and disability onset [12,28]. Unfortunately, mental conditions were
not included in the checklist of diseases in the POLS survey. To
obtain an impression of the extent mental health issues contributeto
the burden of disability, in an additional analysis, we included a
score of 60 or lower on the RAND Mental Health Inventory (MHI-
5) to the diseases, representing (light or severe) mental health
problems[29]. In this analysis, 8–13%of the prevalence ofdisability
was attributed to mental health conditions, at the expense of
contributions of most other disease groups and background (Figure
S1). Together with findings from previous studies, these results
suggest that a substantial part of the burden of disability may be
associated with mental health problems [10,12]. However, as the
MHI-5 is particularly useful for assessing mental health status of the
general population and may lack validity to diagnose individual
cases, the results need to be interpreted with caution. We decided to
provide the results including mental health as supplementary
material instead of presenting them in the main analysis.
Comparison with previous studies
In most previous studies musculoskeletal and cardiovascular
disease were reported as the most important contributors to
disability [4,5,6,7,8,9,11]. Our study confirmed these results also
for the oldest old (80+). Additionally, it was shown that the high
prevalence of disability at this age is caused by a high prevalence of
diseases, but even more by the high extent these diseases lead to
disability at older age. This age dependence was not studied in
most earlier studies. Furthermore, the current study was the first to
identify PVD as an important contributor to the burden of
disability, which is associated with much disability mainly by a
high disabling impact.
Compared with WHOs Global Burden of Disease study, our
method was substantially different [12]. Most importantly, WHOs
approach uses disability weights to quantify burden of disease that
are based on panel valuations and do not refer to physical (or
mental) disabilities only, but represent a broader spectrum of health
loss. Additionally, in this approach, eachcase of disease is assigned a
disability weight, irrespective of individual factors such as age and
sexwhichmayaffectdisablingconsequencesofdiseases,and,hence,
the estimated burden of disease. In the Global Burden of Disease
study, unipolar depressive disorders, alcohol use disorders, hearing
loss (adult onset) and Alzheimer and other dementias were
associated with most years lost due to disability in high income
countries [12]. Differences in methodology and diseases included
hampers further comparison with our results.
Interpretation of results
The high prevalence of disability at older ages reflects both an
increase in the presence of disabling diseases with increasing age
and an increase of the disabling impact. The increasing
contributions of background suggest that at older ages also frailty
or age-related diseases not included in our study may have
contributed [30]. This could for instance be dementia, of which
the prevalence by age shows considerable resemblance with the
pattern of disability attributed to background in our study [31].
Also conditions that caused persisting disability but are no longer
‘present’, e.g. falls, might have contributed [32].
Gender differences in the disabling impact of heart disease, DM,
cancer, arthritis and disorder neck/arm were found. In addition to
differences by gender in self-reporting behavior, differences in
physiological, psychosocial and environmental factors may explain
these variations. For heart disease, a higher disabling impact
among females may be related to a more pronounced decline in
lethality among females than males during the last decades, or to
gender differences in the nature of heart disease causing better
survival among disabled females than among disabled males
[33,34]. For DM, a more negative interference of the disease with
protective mechanisms in the vascular wall causing thrombogen-
esis, and a negative influence of female gender on the effect of
some cardiovascular risk factors are potential causes of the greater
risk for vascular complications in females than in males [35,36,37].
Via cardiovascular complications, these mechanisms may also be
responsible for the larger disabling impact among females. Due to
differences in hormonal factors, coping styles and anxiety, females
are more sensitive to pain than males [38,39,40]. These differences
therefore may also explain the differences in the disabling impact
of arthritis and disorder neck/arm.
Implications; conclusion
This study clearly shows that diseases contribute to the burden
of disability by high disabling impacts, e.g. stroke in males, by
moderate disabling impacts but high prevalences, e.g. arthritis, or
by both high prevalences and disabling impacts, e.g. back pain in
females. Diseases that only have a high disabling impact, e.g.
stroke in females, or only a high prevalence, e.g. heart disease in
males, do not necessarily contribute much to the burden of
disability. The current results showed that the largest contributors
are musculoskeletal disorders, particularly arthritis, and CVD. For
policy makers this means that the largest reductions in the burden
of disability can be obtained by interventions that prevent the
primary cause of disability, i.e. that prevent disease onset. Further
reductions can be achieved by diminishing disabling impacts.
Evidence is accumulating that effective interventions to reduce the
extent diseases cause disability, such as home visit and exercise
programs, are increasingly available [41,42]. As frail elderly are
particularly vulnerable to disability, this group should receive
priority [43,44]. The coming decades, the population of oldest old
will increase massively, i.e. in 2050 about a quarter of the
population of 50 years and older is expected to be older than 80
[45]. The large burden of disability at this age shows that




Figure S1 Prevalence of disability by cause, including ill
mental health. Abbreviations: CNSLD = chronic non-specific
lung disease; CVD = cardiovascular disease; DM = diabetes
mellitus; PVD = peripheral vascular disease (upper extremity
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tions of specific diseases to the prevalence of disability were
estimated on the basis of diseases prevalence and disabling impact
in the study sample from the POLS health and labor survey, the
Netherlands, 2001-2007. The disabling impact represents the rate
of disability from a specific cause given that the disease is present.
Adding specific disability rates for the diseases present and the
background rate of disability (by age and gender) gives the total
disability rate for a specific exposure group. The contributions of
specific diseases presented in the figure add up to the total
prevalence of disability. The total prevalence for females
aged.=80 is higher than in the original analysis, which may be




Conceived and designed the experiments: BK WJN CWL JPM. Performed
the experiments: BK. Analyzed the data: BK. Contributed reagents/
materials/analysis tools: WJN CWL. Wrote the paper: BK. Helped
revising the paper: WJN CWL JPM. Supervised the study: WJN.
References
1. Fried TR, Bradley EH, Williams CS, Tinetti ME (2001) Functional disability
and health care expenditures for older persons. Arch Intern Med 161:
2602–2607.
2. Verbrugge LM, Patrick DL (1995) Seven chronic conditions: their impact on US
adults’ activity levels and use of medical services. Am J Public Health 85:
173–182.
3. Kovacs FMMDP, Abraira VP, Zamora JP, Teresa Gil del Real MMPH,
Llobera JMDMPH, et al. (2004) Correlation Between Pain, Disability, and
Quality of Life in Patients With Common Low Back Pain. Spine (Phila Pa 1976)
29: 206–210.
4. Mathers CD (1999) Gains in health expectancy from the elimination of diseases
among older people. Disabil Rehabil 21: 211–221.
5. Nusselder WJ, Looman CW (2004) Decomposition of differences in health
expectancy by cause. Demography 41: 315–334.
6. Nusselder WJ, Looman CW, Mackenbach JP, Huisman M, van Oyen H, et al.
(2005) The contribution of specific diseases to educational disparities in
disability-free life expectancy. Am J Public Health 95: 2035–2041.
7. Nusselder WJ, van der Velden K, van Sonsbeek JL, Lenior ME, van den Bos GA
(1996) The elimination of selected chronic diseases in a population: the
compression and expansion of morbidity. Am J Public Health 86: 187–194.
8. Picavet HS, van den Bos GA (1997) The contribution of six chronic conditions
to the total burden of mobility disability in the Dutch population. Am J Public
Health 87: 1680–1682.
9. Spiers NA, Matthews RJ, Jagger C, Matthews FE, Boult C, et al. (2005) Diseases
and impairments as risk factors for onset of disability in the older population in
England and Wales: findings from the Medical Research Council Cognitive
Function and Ageing Study. J Gerontol A Biol Sci Med Sci 60: 248–254.
10. Sousa RM, Ferri CP, Acosta D, Albanese E, Guerra M, et al. (2009)
Contribution of chronic diseases to disability in elderly people in countries with
low and middle incomes: a 10/66 Dementia Research Group population-based
survey. Lancet 374: 1821–1830.
11. Jagger C, Matthews R, Matthews F, Robinson T, Robine JM, et al. (2007) The
burden of diseases on disability-free life expectancy in later life. J Gerontol A Biol
Sci Med Sci 62: 408–414.
12. World Health Organization (2008) The global burden of disease: 2004 update.
Geneva: World Health Organisation. ISBN 978 92 4 156371 0 ISBN 978 92 4
156371 0.
13. Freedman VA, Martin LG (2000) Contribution of chronic conditions to
aggregate changes in old-age functioning. Am J Public Health 90: 1755–1760.
14. Puts MT, Deeg DJ, Hoeymans N, Nusselder WJ, Schellevis FG (2008) Changes
in the prevalence of chronic disease and the association with disability in the
older Dutch population between 1987 and 2001. Age Ageing 37: 187–193.
15. Manton KG, Stallard E (1984) Recent trends in mortality analysis. OrlandoFL:
Academic Press.
16. Clayton D, Hills M (1993) Statistical models in epidemiology. Oxford: Oxford
University Press.
17. Davis P, Tso M-S (1982) Procedures for reduced rank regression. Appl Stat 31:
244–255.
18. Yee T, Hastle T (2003) Reduced-rank vector generalized linear models.
Statistical modelling 3: 15–41.
19. Fletcher R (1970) A new approach to variable metric algorithms. The Computer
Journal 13: 317–322.
20. Sullivan DF (1971) A single index of mortality and morbidity. HSMHA health
reports 86: 347–354.
21. European health expectancy monitoring unit (EHEMU) (2010) EHEMU
database & information system. Paris.
22. Efron B, Tibshirani RBR, FL: (1993) An Introduction to the Bootstrap. oca
Raton, London, New York, Washington, D.C., Chapman & Hall/CRC.
23. Stam S, Knoops K (2009) Lange tijdreeksen gezonde levensverwachting.
Beschikbaarheid van enqu ˆetedata gezondheidsindicatoren. Den Haag/Heerlen:
Statistics Netherlands.
24. Klerk M (2005) Landelijk overzicht van de leefsituatie van oudere tehuisbew-
oners. the Hague: The Netherlands Institute for Social Research.
25. The Netherlands Institute for Social Research (2006) Rapportage ouderen 2006.
Veranderingen in de leefsituatie en levensloop. The Hague: The Netherlands
Institute for Social Research.
26. Kriegsman DM, Penninx BW, van Eijk JT, Boeke AJ, Deeg DJ (1996) Self-
reports and general practitioner information on the presence of chronic diseases
in community dwelling elderly. A study on the accuracy of patients’ self-reports
and on determinants of inaccuracy. J Clin Epidemiol 49: 1407–1417.
27. Hubert HB, Bloch DA, Oehlert JW, Fries JF (2002) Lifestyle habits and
compression of morbidity. J Gerontol A Biol Sci Med Sci 57: M347–351.
28. van Gool CH, Kempen GI, Penninx BW, Deeg DJ, Beekman AT, et al. (2005)
Impact of depression on disablement in late middle aged and older persons:
results from the Longitudinal Aging Study Amsterdam. Soc Sci Med 60: 25–36.
29. Berwick DM, Murphy JM, Goldman PA, Ware JE, Jr., Barsky AJ, et al. (1991)
Performance of a five-item mental health screening test. Med Care 29: 169–176.
30. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, et al. (2001) Frailty in
older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:
M146–156.
31. Poos M (2009) Dementie. Omvang van het probleem. Prevalentie, incidentie en
sterfte naar leeftijd en geslacht. Bilthoven.
32. Stel VS, Smit JH, Pluijm SM, Lips P (2004) Consequences of falling in older men
and women and risk factors for health service use and functional decline. Age
Ageing 33: 58–65.
33. Statistics Netherlands (2007) Gezondheid en zorg in cijfers 2007. Voorburg/
Heerlen: Statistics Netherlands.
34. Kattainen A, Reunanen A, Koskinen S, Martelin T, Knekt P, et al. (2004)
Disability predicted mortality in men but not women with coronary heart
disease. J Clin Epidemiol 57: 513–521.
35. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, et al. (1998) Adverse
effects of diabetes on multiple cardiovascular disease risk factors in women. The
Strong Heart Study. Diabetes Care 21: 1258–1265.
36. Juutilainen A, Kortelainen S, Lehto S, Ronnemaa T, Pyorala K, et al. (2004)
Gender difference in the impact of type 2 diabetes on coronary heart disease risk.
Diabetes Care 27: 2898–2904.
37. Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, et al. (2000) Type
II diabetes abrogates sex differences in endothelial function in premenopausal
women. Circulation 101: 2040–2046.
38. Truchon M (2001) Determinants of chronic disability related to low back pain:
towards an integrative biopsychosocial model. Disabil Rehabil 23: 758–767.
39. Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL, 3rd
(2009) Sex, gender, and pain: a review of recent clinical and experimental
findings. J Pain 10: 447–485.
40. Wiesenfeld-Hallin Z (2005) Sex differences in pain perception. Gend Med 2:
137–145.
41. Rejeski WJ, Marsh AP, Chmelo E, Prescott AJ, Dobrosielski M, et al. (2009) The
Lifestyle Interventions and Independence for Elders Pilot (LIFE-P): 2-year
follow-up. J Gerontol A Biol Sci Med Sci 64: 462–467.
42. Stuck AE, Egger M, Hammer A, Minder CE, Beck JC (2002) Home visits to
prevent nursing home admission and functional decline in elderly people:
systematic review and meta-regression analysis. Jama 287: 1022–1028.
43. Daniels R, van Rossum E, de Witte L, Kempen GI, van den Heuvel W (2008)
Interventions to prevent disability in frail community-dwelling elderly: a
systematic review. BMC Health Serv Res 8: 278.
44. Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GB, Jr., et al. (2004)
Designing randomized, controlled trials aimed at preventing or delaying
functional decline and disability in frail, older persons: a consensus report.
J Am Geriatr Soc 52: 625–634.
45. Statistics Netherlands (2010) Statline databank\Bevolking\Prognose\Actuele
prognose\Bevolkingsprognose 2008-2050. Staistics Netherlands, the Hague/
Heerlen.
Contribution of Chronic Disease to Disability
PLoS ONE | www.plosone.org 8 September 2011 | Volume 6 | Issue 9 | e25325